The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001
An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process Source: Eur Respir J 2004; 24: Suppl. 48, 592s Year: 2004
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008
Targeting TNF-alpha in inflammatory lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Impact of cytokines on endothelium in COPD patients Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003